by Morten Bryhn, MD, PHD Mild cognitive impairment & DHA support
brain health naturally Mild cognitive impairment (MCI) is
considered to be a very early stage of Alzheimer’s disease, a
stage when it may be possible to halt the degenerative process
in the brain responsible for Alzheimer’s. Although there are
several pharmaceuticals on the market that are used for treating
this devastating mental disease, long-term results show that
there is only little gain in symptom relief. Alzheimer’s disease
is the end stage of an inflammatory process in the brain that
has been going on for a number of years. Just like other chronic
degenerative diseases, it is important to spot symptoms as early
as possible, when there is still a chance for a successful
reversal of the process. Take type 2 diabetes, for example.
Scientists have identified metabolic syndrome as an early stage
of the disease, and metabolic syndrome responds very well to
treatment. MCI may represent the same opportunity to identify
people who are at risk for